Back to Clinics or Pharmacies

Notice: Clinic adding £10 charge to patients exercising their right to choose their own pharmacy, breaking both GMC and BMA guidelines.
Mamedica® Access Scheme is limited to benefit recipients and veterans only. (UC, JSA, PIP, DLA, ESA, LCWRA)
One-off £200 payment which includes all continual consultation/repeats fees for qualifying new patients, subject to approval.
Limit of utilising one pharmacy per month, with one script written for full 30 day supply.
£10 prescription handling fee when utilising pharmacies other than Mamedica® Dispensary.

Company Registration Details

This organisation is listed on Companies House as Mamedica Ltd, further details on then link below.

British Crown Icon View on Companies House

Care Quality Commission Report

Overall
Good

Safe
Good
Effective
Good
Caring
Good
Responsive
Good
Well-Led
Requires Improvement

Inspected on 7th June 2023

Preferred Pharmacy

Mamedica® Dispensary Logo

To the best of our knowledge Mamedica® Dispensary is the default pharmacy patients are referred to for this clinic.

Opening Times

Monday
9:00am to 6:00pm
Tuesday
9:00am to 6:00pm
Wednesday
9:00am to 6:00pm
Thursday
9:00am to 6:00pm
Friday
9:00am to 6:00pm
Saturday
Closed
Sunday
Closed
Clinic DescriptionPatient Reviews

About MAS

We exist to improve the lives of patients by pioneering medical cannabis.

Clinic Price List

0 0
Sign-Up Consultation £200.00
Travel Letter Fee Free

Information on Appointment Pricing

It costs £200.00 for an initial sign-up consultation at MAS as a new patient. Generally, most clinics will offer a free initial screening assessment; sometimes by online questionnaire, in other cases simply by calling and talking to clinic staff about your specific condition(s).

0

Further Information & Patient Sign-Up for MAS

This page was last updated:

  Information provided is partially community sourced and may be outdated or otherwise incorrect. Please report any inaccuracies found by email.

NHS LogoFurther National Health-Service Information on Cannabis-Based Products for Medicinal Use (CBPMs)